We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CBO Says Medicare Drug Negotiations Bill Could Result in 60 Fewer New Drugs Over Three Decades
CBO Says Medicare Drug Negotiations Bill Could Result in 60 Fewer New Drugs Over Three Decades
The number of new drugs expected to come into the marketplace will drop by 60 over the next 30 years due to effects of the Medicare drug price negotiations bill H.R. 3, the Congressional Budget Office (CBO) said in a new report.